Ann-Kathrin Eisfeld | Molecular Profiles | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Ann-Kathrin Eisfeld | Molecular Profiles | Best Researcher Award

The Ohio State University | United States

Dr. Ann-Kathrin Eisfeld is an internationally recognized physician-scientist and Associate Professor with Tenure in the Division of Hematology at The Ohio State University, where she also serves as Director of the Clara D. Bloomfield Center for Leukemia Outcomes Research. Her research focuses on the molecular and genetic underpinnings of acute myeloid leukemia (AML), with a particular emphasis on translational applications that improve patient outcomes. Dr. Eisfeld has published extensively in high-impact journals such as Nature, Leukemia, Blood, and Cell Stem Cell, contributing significantly to our understanding of leukemia biology, clonal evolution, and treatment resistance. she has authored over 100 peer-reviewed scientific publications, with an h-index of 38, more than 6,500 citations, and has led or co-led multiple collaborative studies within national consortia such as the Alliance for Clinical Trials in Oncology. Her work has identified critical biomarkers and therapeutic targets in AML, including insights into TP53 mutations, FLT3 alterations, and resistance mechanisms to venetoclax. Recognized for her integration of clinical insight with cutting-edge genomics, Dr. Eisfeld is a leading voice in precision oncology and leukemia research, shaping the future of individualized treatment strategies through both clinical innovation and scientific discovery.

Profile: Scopus

Featured Publications:

“Highly elevated serum hepcidin in patients with acute myeloid leukemia prior to and after allogeneic hematopoietic cell transplantation: Does this protect from excessive parenchymal iron loading?”

“Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia”

“miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia”

“Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia”

“Kinetics of iron removal by phlebotomy in patients with iron overload after allogeneic hematopoietic cell transplantation”

“inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations”

“Clinical Role of microRNAs in Cytogenetically Normal Acute Myeloid Leukemia: miR-155 Upregulation Independently Identifies High-Risk Patients”

“In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline”

“A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia”

Suchit Sarin | Tissue Engineering Regeneration | Best Researcher Award

Published on by Cell Biologist

Dr. Suchit Sarin | Tissue Engineering Regeneration | Best Researcher Award

Dr. Suchit Sarin | University of Nebraska Lincoln | United States

Dr. Suchit Sarin is an accomplished materials engineering researcher with over 12 years of academic and research experience in microstructural analysis, materials characterization, and process development. With a passion for advancing materials science, he has contributed extensively through his Ph.D. work at the University of Nebraska-Lincoln, where he has excelled in the use of advanced instrumentation like SEM/FIB, TEM, STEM, and XRD. Suchit has trained over 50 users on high-precision tools and worked with cross-functional teams from academia and industry. He has authored/co-authored more than 15 peer-reviewed publications in high-impact journals and conference proceedings. His research in laser surface engineering, thin films, nanostructures, and thermal materials showcases his interdisciplinary strengths. Suchit’s commitment to scientific rigor, hands-on technical expertise, and collaborative spirit make him a strong candidate for recognition as a leading researcher in his field.

Publication Profiles: 

Google Scholar
Scopus

Education:

Suchit Sarin holds a Ph.D. in Materials Engineering from the University of Nebraska-Lincoln, where he specialized in laser-material interactions, advanced microscopy, and functional surface design. Prior to this, he earned his Master of Science by Research in Metallurgical Engineering and Materials Science from the Indian Institute of Technology Bombay. His graduate and doctoral studies have involved rigorous experimental and theoretical work, particularly in nano/micro-structuring, thermophysical properties, and magnetic materials. Throughout his academic journey, Suchit demonstrated academic excellence, technical leadership, and strong communication skills. His education provided a solid foundation in both fundamental and applied aspects of materials science, further strengthened by his exposure to interdisciplinary collaborations, hands-on equipment management, and industrial partnerships. This unique academic profile has positioned him at the forefront of innovation in functional materials and energy-efficient surface technologies.

Experience:

Suchit Sarin served as the Instrument Manager for the FEI Helios NanoLab 660 DualBeam SEM/FIB at the Nano-Engineering Research Core Facility in Lincoln, NE. He conducted over 50 training sessions and ensured operational excellence through regular maintenance and calibration. He prepared advanced samples, including electron-transparent foils, nano-slits, and nanopillars, and characterized a wide range of materials—from semiconductors to geological specimens. His collaboration extended beyond academia to industrial partners such as Li-Cor Biosciences and Monolith. His earlier academic research involved synthesis, oxidation behavior, and coatings in high-temperature materials. Suchit is proficient with TEM, STEM, XRD, DSC, and simulation tools like CALPHAD (ThermoCalc), positioning him as a multidisciplinary researcher with both technical depth and cross-functional experience. His leadership in instrumentation and collaboration makes him an integral contributor to both the research ecosystem and industry-relevant innovation.

Research Focus:

Suchit Sarin’s research focuses on surface functionalization, micro/nanostructuring, and advanced materials characterization. A central theme in his work is understanding and engineering the interaction of ultrashort laser pulses with various materials to develop structures with enhanced thermal, magnetic, and catalytic properties. He has significantly contributed to the development of self-organized nano/microstructures on metals and semiconductors using femtosecond laser processing. His research has implications in energy transfer, heat dissipation, catalysis, and spintronics. He employs advanced tools like SEM/FIB, TEM/STEM, XRD, and DSC to understand structure-property relationships at multiple length scales. Additionally, he has worked on plasma-assisted catalysis and magnetic thin films, contributing to innovations in clean energy and electronics. His multidisciplinary approach integrates experimental analysis with industrial problem-solving, offering practical solutions grounded in fundamental science. With over 15 high-impact publications, Suchit’s research stands out for both its novelty and real-world applicability.

Publications Top Notes: 

  1. Growth mechanisms of micro/nano-structures from ultrashort laser ablation on copper – Applied Surface Science

  2. Graph theory to quantify femtosecond laser-processed copper surfaces – Surfaces and Interfaces

  3. Laser-induced quasi-periodic surface structures for enhanced vapor chamber cooling – Advanced Functional Materials

  4. Logarithmic trends in microstructures on femtosecond-lasered silicon – SPIE Proceedings

  5. Spin-wave propagation in thulium iron garnet thin films – Advanced Electronic Materials

  6. Plasma-assisted methanol synthesis via CO₂ hydrogenation – ChemSusChem

  7. Room-temperature magnetic skyrmions in CoPt thin films – ACS Nano

  8. Copper surface functionalization via femtosecond laser processing – SPIE Proceedings

  9. Pool boiling enhancement using femtosecond-processed aluminum – IEEE ITherm

  10.  Dual-channel boiling heat transfer on laser-processed steel – IEEE ITherm

Conclusion:

In conclusion, Dr. Suchit Sarin is a highly deserving candidate for the Best Researcher Award. His exceptional contributions to the field of materials science, especially in surface functionalization, electron microscopy, and energy-related applications, make him a standout nominee. With a proven track record of impactful publications, collaborative spirit, and commitment to mentorship and instrumentation excellence, he embodies the qualities of a researcher who not only pushes the boundaries of knowledge but also fosters the growth of the scientific community. With continued development in leadership and broader dissemination, he is well-poised to become a leading figure in the global materials research landscape.

 

 

Pryanka Thakur | Dengue | Young Scientist Award

Published on by Cell Biologist

Dr. Pryanka Thakur | Dengue | Young Scientist Award

Dr. Pryanka Thakur | Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh | India

Dr. Pryanka Thakur is a dedicated virologist and Project Research Scientist-I at PGIMER, Chandigarh, working in Professor Sunil Sethi’s laboratory. She earned her Ph.D. in Virology from PGIMER under the mentorship of Professor (Dr.) Radha Kanta Ratho, Dean of PGIMER. Her research revolves around molecular pathogenesis, particularly focusing on viral diseases such as Dengue, COVID-19, Hepatitis E, and emerging zoonotic threats. With numerous high-impact publications and presentations at national and international forums, Dr. Thakur has built a commendable academic and research portfolio. Her work contributes to a deeper understanding of viral mechanisms and their public health implications. She has received accolades like the Young Scientist Award and DST-SERB travel grant, reflecting her potential as a rising star in infectious disease research. Passionate about molecular diagnostics and disease pathogenesis, Dr. Thakur’s academic rigor and commitment position her as a promising candidate for the Research for Young Scientist Award.

Publication Profile: 

Orcid

Scopus

Education:

Dr. Pryanka Thakur completed her Ph.D. in Virology at the prestigious Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, from August 2018 to March 2024. Her thesis, titled “Role of inflammasome and autophagy in the pathogenesis of severity of Dengue fever,” was conducted under the supervision of Professor (Dr.) Radha Kanta Ratho, a leading authority in virology. Her doctoral work explored critical host-pathogen interactions, offering insights into mechanisms influencing disease severity. During this period, she honed her skills in molecular virology, diagnostics, and cellular biology. Her academic foundation is deeply rooted in translational and clinical virology, with particular emphasis on autophagy, inflammasomes, and immunological responses during viral infections. Through her rigorous training and extensive hands-on experience with cutting-edge lab techniques, she emerged as a well-rounded scientist with both technical expertise and conceptual depth in infectious disease research, specifically RNA viruses and M. tuberculosis.

Experience:

Dr. Pryanka Thakur currently serves as a Project Research Scientist-I in the Department of Medical Microbiology, PGIMER, Chandigarh, under the mentorship of Professor Sunil Sethi. Her research has primarily focused on virological and immunological responses to emerging and re-emerging infections. She has extensive experience in molecular biology, cell culture, diagnostics, and bioinformatics, contributing to major national and international research initiatives. During her Ph.D., she contributed significantly to studies on Dengue pathogenesis, SARS-CoV-2 evolution, and the intersection of autophagy and inflammasome activity. Her experience also includes collaboration with clinicians, epidemiologists, and diagnostic labs, showcasing her ability to work in interdisciplinary settings. Beyond lab work, she has actively participated in scientific writing, mentoring junior researchers, and presenting findings at forums like ECCMID and VIROCON. Her track record reflects a strong combination of leadership, innovation, and research integrity—making her a standout young investigator.

Awards and Honors:

Dr. Pryanka Thakur’s excellence in research has been recognized through prestigious accolades. In 2024, she was honored with the Young Scientist Award at the VIROCON 2024 conference held at DRDE, Gwalior, for her impactful Ph.D. research on Dengue virus pathogenesis. Additionally, she secured the highly competitive DST-SERB International Travel Grant to present her work at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark. These honors are a testament to the significance and quality of her research in infectious diseases. Her recognition on both national and international platforms demonstrates her rising reputation within the scientific community. These awards not only validate her current achievements but also underscore her potential for future contributions to global health challenges. Her work continues to resonate with experts in virology, public health, and molecular diagnostics—solidifying her status as a promising candidate for further research awards.

Research Focus:

Dr. Pryanka Thakur’s research is rooted in the pathogenesis, immunology, and molecular biology of emerging infectious diseases. Her Ph.D. research dissected the intricate roles of inflammasome activation and autophagy dysregulation in severe Dengue infections—paving the way for targeted therapies and better clinical outcomes. She also actively investigates RNA viruses, including SARS-CoV-2, Hepatitis E, Monkeypox, Nipah, and avian influenza, exploring their mutation patterns, immune evasion strategies, and pandemic potential. Her recent studies also delve into co-infections (e.g., Dengue and COVID-19 in pregnancy), and the reemergence of known pathogens in the post-pandemic era. Dr. Thakur maintains a special interest in molecular diagnostics, enabling early and accurate disease detection. Her contributions bridge laboratory science with clinical relevance, aiming to develop diagnostic tools and deepen our understanding of host-pathogen dynamics. This interdisciplinary approach positions her to make substantial contributions to the field of translational virology and public health microbiology.

Publications Top Notes: 

  1. Waves and variants of SARS-CoV-2: Understanding the causes and effect of the COVID-19 catastrophe – Infection, 2022.

  2. Viral Hepatitis E and Chronicity: A growing public health concern – Frontiers in Microbiology, 2020.

  3. Monkeypox virus in humans: A concern – Trespassing global boundaries – Int J Surg, 2022.

  4. Emergence of novel omicron hybrid variants: BA(x), XE, XD, XF – More than just alphabets – Int J Surg, 2022.

  5. Nipah Outbreak: Beginning of another pandemic in the era of COVID-19 and Zika? – Brain Behav Immun, 2021.

  6. Evolutionary dynamics of emergent SARS-CoV-2 variants: Just within a year – Immunome Research, 2021.

  7. Avian influenza revisited: Concerns and constraints – VirusDisease, 2022.

  8. Maternal and perinatal outcome in Dengue and COVID-19 co-infected pregnancies – Eur J Obstet Gynecol Reprod Biol, 2023.

  9. Post-COVID-19 era: Re-emergence of known and future (X) viral pathogens – Vacunas, 2024.

  10.  Paclitaxel production from endophytic Mucor circinelloides from Himalayan Taxus sp. – 3 Biotech, 2024.

Conclusion:

In conclusion, Dr. Pryanka Thakur is an exceptionally well-qualified candidate for the Research for Young Scientist Award. Her academic rigor, publication excellence, and strong interest in infectious disease pathogenesis make her a standout young researcher. She brings a unique blend of molecular insights and public health relevance to her work, making significant contributions to understanding emerging viral threats. With national recognition and international exposure already under her belt, she is on a clear upward trajectory in academic science. Supporting her at this stage through the Young Scientist Award would not only validate her past contributions but also empower her to lead future advancements in virology, diagnostics, and translational medical research. With minor enhancements in project independence and translational focus, Dr. Thakur is poised to become a future leader in infectious disease research, making her a deserving recipient of this award.

 

Sharmil Suganya.R | Biotechnology | Best Researcher Award

Published on by Cell Biologist

Prof. Sharmil Suganya.R | Biotechnology | Best Researcher Award

Prof. Sharmil Suganya.R, Government College of Engineering, India

Prof. R. Sharmil Suganya is a dedicated academic and researcher currently serving as Assistant Professor (Senior Scale) in the Department of Electrical and Electronics Engineering (Bio-Engineering Division) at the Government College of Engineering, Salem. With over 17 years of academic experience, she has significantly contributed to multidisciplinary fields, especially biocorrosion, eco-friendly inhibitors, and biomedical instrumentation. She began her teaching career at Bharath University and later joined GCE, Salem, where she continues to mentor students and contribute to research and innovation. Her scholarly work spans numerous national and international journals and conferences, and she has co-authored over 15 papers and earned accolades through patents and impactful publications. She is well-recognized in academia with profiles on Vidwan, ORCID, and Google Scholar. Her work is marked by a strong commitment to sustainable, application-oriented research and technological innovation.

Publication Profile: 

Google Scholar

🌟 Strengths Supporting Award:

  1. Diverse Interdisciplinary Research
    Prof. Suganya bridges Biotechnology, Biomedical Instrumentation, Environmental Chemistry, and Embedded Systems—reflecting her adaptability and wide impact across disciplines.

  2. Rich Publication Record

    • Peer-reviewed journals: >15 high-quality papers including Web of Science, UGC Care, Scopus, and SCI journals.

    • Recent impactful studies: Publications in Journal of Molecular Structure, Scientia Iranica, Bulletin of the Chemical Society of Ethiopia, etc.

    • Design Patents: UK patents for a Fluorometer and a Distillation Apparatus, showing innovation beyond academics.

  3. Applied and Sustainable Research Focus

    • Contributions to green inhibitors, corrosion prevention, eco-friendly water treatment, and energy-efficient designs show her commitment to sustainability.

    • Projects like Irrigation Monitoring Systems and Induction Motor Monitoring show a hands-on engineering application.

  4. Collaborative Spirit and Mentorship

    • Multiple co-authored works with students and peers indicate strong mentorship and team leadership.

    • Research involving simulation, design, and in vitro experiments demonstrates technical skill and guidance in both computational and experimental domains.

  5. Long-standing Service & Institutional Contribution
    Over 15 years of service in Tamil Nadu Engineering Education (including DOTE & GCE Salem) reflects dedication to academic growth and public education.

🔧 Areas for Improvement:

  1. Funding and Sponsored Projects

    • While publications and patents are notable, securing national/international research grants (e.g., DST, SERB, DBT, AICTE) would significantly enhance her research stature.

  2. International Collaboration

    • Expanding collaboration with foreign universities or research groups can elevate her global research impact and visibility.

  3. Citation Metrics & H-index

    • Although her Google Scholar profile shows productivity, citation metrics could be improved through more high-impact, open-access publications and targeted dissemination.

  4. Technology Transfer / Start-up Engagement

    • Converting patents into commercial products or licensing would further reflect translational research excellence.

🎓 Educational Background:

Prof. R. Sharmil Suganya holds a B.Tech. in Biotechnology from Bharathidasan University (2004), securing First Class with 72%. She pursued her postgraduate studies in M.Sc. Biomedical Instrumentation Science at Loyola College, Chennai (Madras University) in 2006, graduating with distinction (82%). Further enhancing her academic credentials, she earned an M.S. by Research in Faculty of Technology from Anna University through the Government College of Engineering, Salem, completing it with a successful viva voce on 24.06.2020. Her multidisciplinary academic foundation combines life sciences, engineering, and technology, enabling her to bridge research across biotechnology, biomedical engineering, and electrical systems. Her educational path reflects her strong grounding in both theory and applied research, making her a versatile contributor to both academia and industry-oriented innovation.

🧑‍🏫 Academic Experience:

Prof. Sharmil Suganya began her career in 2006 as a Lecturer at Bharath University, Chennai, gaining nearly two years of foundational teaching experience. In 2008, she was appointed as an Assistant Professor via redeployment at the Directorate of Technical Education, Chennai, serving for over six years. Since 2014, she has been a part of GCE, Salem, now totaling over 17 years of teaching experience as of 2025. Her roles have included curriculum development, research mentorship, lab design, and departmental initiatives. She has guided numerous student projects, contributed to research publications, and participated in sponsored national conferences and TEQIP-funded programs. Her long tenure and steady progression demonstrate a career built on academic rigor, professional integrity, and a passion for engineering education with a bioengineering focus.

🔬 Research Focus:

Prof. R. Sharmil Suganya’s research encompasses biocorrosion, eco-friendly corrosion inhibitors, biomedical sensors, instrumentation systems, and environmental sustainability. Her core focus lies in microbe-induced corrosion (MIC) in metals, particularly mild steel and galvanized steel, and its mitigation using green inhibitors such as Trachyspermum ammi and C. sativum. She integrates materials science, chemical kinetics, and simulation-based approaches like molecular docking and MD simulation in her investigations. Her collaborative and interdisciplinary research has resulted in impactful publications across Web of Science, Scopus, and UGC Care journals, along with patents in distillation and fluorometry technologies. She is also active in IoT-based monitoring systems and instrumentation applications in agriculture and industry, thus contributing to the smart systems domain. Her work has real-world applicability, particularly in the sustainable engineering and bioengineering sectors, making her a strong contender for the Best Researcher Award.

📚 Publications Top Notes: 

  1. 📘 Investigation on MIC of Mild Steel inhibited by Trachyspermum ammi in cooling tower water – Int’l Conf. 2019

  2. 📙 Impedance Study on MIC in Mild Steel immersed in Cooling Tower Water – ETES ’19

  3. 🧪 Adsorption of Hexavalent Chromium from aqueous solution using Ocimum Tenuiflorum stem – Asian J. Res. 2017

  4. 🔍 Investigation on MIC on Mild Steel using Trachyspermum ammi in Cooling Tower Water – JSER, 2021

  5. 🌿 Biocorrosion and inhibition by a green inhibitor on Mild Steel – IJIRSET, 2021

  6. 🚜 Irrigation Monitoring System using NodeMCU & Blynk app – IJIRSET, 2021

  7. ⚙️ Remote Condition Monitoring & Fault Alert System of Induction Motor – IJIREEICE, 2020

  8. 💡 Design of Energy Efficient Lighting Loads in EEE Block at GCE – IJIREEICE, 2020

  9. 🧫 Removal of Methylene Blue using low-cost absorbents – Desalination & Water Treatment, 2023

  10. 🧪 Biocorrosion on Mild Steel and inhibition by C. Sativum – AIMS Mol. Sci, 2024

🏁 Conclusion:

Prof. R. Sharmil Suganya is highly suitable for recognition through a Best Researcher Award. Her record reflects a balanced portfolio of:

  • Innovative interdisciplinary research

  • Student mentorship and collaboration

  • Sustainable and application-oriented work

  • Continued publication and patenting efforts

With enhanced funding pursuits and international networking, she can further scale her impact. Nevertheless, her existing contributions are outstanding in both depth and breadth, making her a strong candidate for this honor.

Maria Andriolo | Host-Pathogen Interactions | Best Innovation Award

Published on by Cell Biologist

Dr. Maria Andriolo | Host-Pathogen Interactions | Best Innovation Award

Dr. Maria Andriolo, ASP CALTANISSETTA, Italy

Maria Andriolo is a dedicated biomedical researcher and clinical biologist with extensive experience in neuroscience, immunology, and post-traumatic disorders. Her multidisciplinary approach has led to impactful contributions in clinical diagnostics, neurorehabilitation, and infectious disease studies. With decades of experience across leading Italian institutions, she combines clinical insight with scientific rigor. She has served in prestigious roles such as a Member of the State Examination Commission and President of Public Selection Committees. Dr. Andriolo is widely published, collaborating on pioneering studies in fields including brain trauma, sepsis diagnostics, and vaccine immunoresponse. Known for her collaborative spirit and leadership, she also contributes as a conference moderator and educator. Her body of work reflects a deep commitment to translational science that benefits patient care and public health.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Multidisciplinary Research Impact
    Dr. Andriolo’s work spans key medical research areas including:

    • Neurology (e.g., traumatic brain injury, disorders of consciousness)

    • Clinical Biochemistry (e.g., neuron-specific enolase, BDNF, CSF biomarkers)

    • Microbiology & Infectious Diseases (e.g., antimicrobial resistance, sepsis diagnostics)

    • Immunology & Vaccine Response (e.g., post-COVID vaccine serology in healthcare workers)

  2. Innovation with Real-World Impact
    Her studies focus on biomarkers for rapid diagnosis, rehabilitation outcomes, and immune responses, directly translating into improved patient care, particularly in:

    • Post-traumatic brain disorders

    • Early detection of sepsis

    • Infection control strategies

  3. Collaborative and High-Impact Publications

    • Extensive peer-reviewed articles in PubMed-indexed journals like Journal of Neurotrauma, Brain Sciences, Vaccines, and Science Reports.

    • Publications show collaborations with leading national research teams and hospitals.

  4. Scientific Leadership & Recognition

    • Appointed as President of National Selection Committees and State Examiner for Biologist Certification.

    • Served as Moderator at ECM Conferences, further demonstrating peer trust and scientific communication skills.

⚠️ Areas for Improvement:

  1. Lead Authorship and Project Ownership

    • While her publication record is strong, she is mostly listed as co-author. Clear documentation of principal investigator roles, research grants led, or independent innovation patents would further bolster her candidacy.

  2. International Presence

    • A broader international profile (e.g., global conferences, cross-border collaborative studies, citations from non-EU entities) could elevate her global impact.

  3. Recent Innovation Highlights

    • A focused submission highlighting a single groundbreaking innovation (e.g., biomarker panel for TBI prognosis or rapid sepsis tool) would align more clearly with “Best Innovation” award criteria.

🎓 Education:

While the detailed educational background isn’t listed, Maria Andriolo’s professional and scientific achievements imply a robust academic foundation in Biology, Neuroscience, and Clinical Diagnostics, likely culminating in at least a Master’s or Doctorate-level education in Biomedical Sciences. Her involvement as a State Examiner for Biologist Qualification and leader of academic committees suggests a longstanding connection with university-level institutions, particularly the University of Messina. Given her expertise and publication record, it is evident she has received specialized training in neurobiology, molecular genetics, clinical chemistry, and medical microbiology. She has actively participated in ECM-accredited medical conferences, indicating a commitment to continuing professional development. This mix of structured education and applied training positions her as a highly qualified scientific professional.

💼 Professional Experience:

Maria Andriolo holds significant academic and clinical leadership roles. She was appointed in July 2024 as a Member of the State Examination Commission for Biologists at the University of Messina, overseeing professional certifications. In June 2023, she served as President of the Examination Committee for a public selection competition for C1 research staff. She is frequently invited to act as a moderator at ECM-accredited conferences, underscoring her peer recognition in the field. Her expertise spans biomedical research, academic evaluation, and public health diagnostics. Maria’s ability to combine scientific knowledge with regulatory oversight and teaching makes her a valuable contributor to academia and public institutions. Her leadership and participation in national scientific initiatives demonstrate her commitment to innovation, clinical application, and academic excellence.

🔬 Research Focus:

Maria Andriolo’s research is anchored in neuroscience, post-traumatic disorders, biomarkers, and infectious diseases. Her work often centers on patients with disorders of consciousness following trauma, analyzing biomarkers like BDNF, neurofilaments, and amyloid-beta proteins. She is a leading contributor in understanding the neurochemical pathways associated with brain injury and rehabilitation. Maria has also co-authored influential studies on sepsis diagnostics, immune response to COVID-19 vaccines, and antimicrobial resistance. Her research combines laboratory diagnostics with clinical applications, enabling faster diagnoses and more effective treatment strategies. She is known for utilizing multidisciplinary frameworks, involving neurologists, microbiologists, and clinicians to translate science into solutions. This strong translational impact underscores her candidacy for the Best Innovation Award, as she bridges the gap between research and patient-centered innovation.

📚 Publications Top Notes:

  1. 🧠 Reduced neuron-specific enolase levels in chronic severe traumatic brain injury

  2. 🧬 Multidisciplinary approach for the rapid diagnosis of sepsis

  3. 💉 Serological analysis of humoral immune response in Sicilian HCWs post-COVID vaccination

  4. 🧠 Dissociation of CSF amyloid-beta and tau in post-traumatic consciousness disorders

  5. 💉 Staphylococcus aureus in bloodstream infections: frequency & antimicrobial resistance

  6. 🧠 Serum BDNF levels are reduced in disorders of consciousness

  7. 🧠 Six-month outcomes in traumatic consciousness disorders (hemorrhagic/non-hemorrhagic)

  8. 🧠 BDNF Val66Met polymorphism and post-traumatic vegetative state recovery

  9. 💉 Anaphylaxis to streptomycin

  10. 🧠 Prolonged CSF neurofilament light chain increase in traumatic brain patients

🏁 Conclusion:

Maria Andriolo is a highly suitable and deserving candidate for the Research for Best Innovation Award. Her research demonstrates:

  • Exceptional depth in translational neuroscience and diagnostics

  • A strong commitment to multidisciplinary collaboration

  • A clear track record of innovation that impacts both patient outcomes and healthcare protocols

 

 

 

Junfeng Zhang | Cancer Cell Biology | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Junfeng Zhang | Cancer Cell Biology | Best Researcher Award

Assoc. Prof. Dr. Junfeng Zhang, Anhui University of Science and Technology, China

Dr. Junfeng Zhang is an Associate Professor and Deputy Director of the Center for Medical Frontiers at the School of Medicine, Anhui University of Science and Technology. With a Ph.D. in biomedical sciences, he has emerged as a leading figure in nanomedicine and cancer theranostics. His work integrates nanotechnology, molecular imaging, and drug delivery systems, particularly focusing on intelligent nanoformulations for tumor targeting and integrated diagnostics and therapy. Dr. Zhang is an active member of multiple national medical committees and has contributed significantly to interdisciplinary research. His publications in prestigious journals like Advanced Materials, Small Methods, and Advanced Science reflect both scientific depth and translational potential. As a council and committee member of several medical and health associations, he actively promotes collaboration across academic and healthcare institutions. His dedication to innovation and public health positions him as a rising star in biomedical engineering and personalized cancer therapy.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. High-Impact Research Contributions

    • Dr. Zhang has published in top-tier international journals such as Advanced Materials (IF: 32.086), Advanced Science (IF: 15.1), and Small Methods (IF: 15.367).

    • His work demonstrates interdisciplinary excellence—combining nanotechnology, oncology, and imaging science to address complex medical challenges.

  2. Innovative Scientific Focus

    • Focused on intelligent theranostic nanoformulations, his research targets both diagnostic imaging and cancer therapy in a single platform.

    • He has developed laser-free imaging systems, nucleus-targeted drug delivery platforms, and responsive nanosystems, which are highly relevant to personalized and precision medicine.

  3. Leadership & Recognition

    • Serves as the Deputy Director of the Center for Medical Frontiers, showing strategic leadership.

    • Holds multiple national-level committee memberships, indicating peer recognition and influence in the field of nuclear medicine, digital health, and environmental mutagen studies.

  4. Collaborative & Global Research Impact

    • Frequently collaborates with international researchers like Prof. Rui L. Reis.

    • Demonstrates versatility in both experimental and translational research, addressing real-world medical and toxicological issues.

  5. Consistent Productivity

    • Maintains a consistent and strong publication record as first/corresponding author over the past five years, with multi-disciplinary themes.

⚠️ Areas for Improvement:

  1. Commercialization & Patent Activity

    • While his work is scientifically advanced, there is limited visible emphasis on patent filings, technology transfer, or startup ventures. Increasing focus here would enhance his profile for innovation-based awards.

  2. International Outreach

    • Although involved in collaborations, more visibility in international scientific conferences, editorial boards, or global awards could further strengthen his candidacy on the world stage.

  3. Public Health Engagement

    • As his work is deeply relevant to cancer management, more visible contributions to community awareness, patient education, or policy advisory roles could broaden the societal impact of his research.

🎓 Education:

Dr. Junfeng Zhang earned his doctoral degree (Ph.D.) in biomedical sciences, with a specialization in nanomedicine and molecular diagnostics. While the specific university name is not listed, the rigorous research output suggests training from a high-caliber institution. His education integrated core principles of pharmacology, biomedical engineering, and cancer biology, allowing him to build a strong foundation in interdisciplinary medical research. During his academic career, he focused on translational research that merges engineering, imaging technologies, and clinical applications. Through his doctoral training, Dr. Zhang acquired advanced techniques in nanoparticle synthesis, fluorescence imaging, and drug delivery. His education paved the way for impactful research in photoacoustic imaging and intelligent targeted therapies. Dr. Zhang’s academic background equipped him to lead cutting-edge research projects that align with global challenges in oncology. He continues to leverage his academic foundation to mentor graduate students and drive innovation in healthcare technology development.

🧪 Experience:

Dr. Zhang currently serves as Associate Professor and Deputy Director of the Center for Medical Frontiers at the School of Medicine, Anhui University of Science and Technology. He holds prominent roles including Council Member of the Anhui Provincial Society of Environmental Mutagens and committee memberships in nuclear medicine and digital health bodies. With over five years of experience in biomedical research and teaching, he has led numerous research projects at the interface of nanomedicine, cancer biology, and imaging diagnostics. His international collaborations and editorial contributions signify global recognition. As a mentor, he guides students and young researchers in clinical translation of nano-based therapies. His leadership at the Center for Medical Frontiers emphasizes high-impact innovation, collaborative research culture, and practical solutions to oncological diseases. His diverse experience in academic, clinical, and committee roles demonstrates his comprehensive influence in shaping future medical technologies and public health strategies.

🔬 Research Focus:

Dr. Zhang’s research focuses on the development of intelligent theranostic nanoformulations aimed at achieving both diagnosis and treatment of tumors in a single platform. His work emphasizes dual-mode imaging systems (photoacoustic/fluorescence), targeted drug delivery, and biocompatible nanocarriers capable of bypassing biological barriers. One of his key innovations involves creating gold- and carbon-based nanomaterials for laser-free imaging and mitochondrial apoptosis induction. He is particularly interested in nucleus-targeted therapies, precision drug delivery, and responsive nanosystems that adjust to tumor microenvironments. He also studies the toxicological aspects of nanomedicines under various physiological conditions, including magnetic field exposure and metabolic pathway disruptions. His research bridges disciplines like pharmacology, materials science, and medical imaging, contributing to the personalized medicine movement. With a strong publication record in high-impact journals, his research focus reflects a commitment to translating laboratory innovations into clinical applications to improve cancer diagnosis, treatment precision, and therapeutic outcomes.

📚 Publications Top Notes:

  1. 🧬 A Multifunctional Photoacoustic/Fluorescence Dual-Mode-Imaging Gold-Based Theranostic Nanoformulation without External Laser Limitations – Advanced Materials, 2022

  2. 💊 An Efficient Carbon-Based Drug Delivery System for Cancer Therapy through the Nucleus Targeting and Mitochondria Mediated Apoptotic Pathway – Small Methods, 2021

  3. 🧠 Humanistic Health Management and Cancer: Associations of Psychology, Nutrition, and Exercise with Cancer Progression and Pathogenesis – Advanced Science, 2024

  4. 🌿 Preparation, Characterization, and Evaluation of the Antitumor Effect of Kaempferol Nanosuspensions – Drug Delivery and Translational Research, 2023

  5. 🐟 High Concentrations of Fluorescent Nanoprobes Delayed Oryzias Melastigma Embryo Hatching by Modulating Respiratory and Metabolic Pathways – VIEW, 2025

  6. 🧲 The Biokinetics and Toxicology of Fe₃O₄ Nanoparticles Influenced by Magnetic Field and Protein – Nano, 2022

🧾 Conclusion:

Dr. Junfeng Zhang is a highly suitable and deserving candidate for the Best Researcher Award. His cutting-edge work in nanomedicine, combined with consistent high-impact publications, academic leadership, and contributions to national scientific bodies, clearly mark him as a rising and influential scientist in the medical research community. With slight enhancements in technology translation and international public engagement, he holds potential to become a global leader in biomedical innovation.

Lingyan Zhou | Cell Death Pathway | Best Researcher Award

Published on by Cell Biologist

Dr. Lingyan Zhou | Cell Death Pathway | Best Researcher Award

Dr. Lingyan Zhou , Shandong Provincial Hospital Affiliated to Shandong First Medical University , China

Dr. Lingyan Zhou is a dedicated neuroscientist and clinician specializing in the pathogenesis of neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease. Currently serving in the Department of Neurology at Shandong Provincial Hospital affiliated with Shandong First Medical University, Dr. Zhou holds a doctorate and has made notable contributions to neurodegeneration research through high-impact publications and cutting-edge studies. Her work focuses on molecular mechanisms such as protein aggregation, homocysteinylation, and neuroprotection, with particular attention to α-synuclein and DJ-1. Dr. Zhou has co-authored more than 15 peer-reviewed articles in top-tier journals like Nature Communications, Science Advances, and Aging Cell, earning recognition for her insights into disease-modifying pathways. A researcher with a strong translational focus, she bridges the gap between bench and bedside, aiming to develop therapeutic strategies that can mitigate or reverse neurodegenerative processes. Her commitment to science and patient-centered research makes her a strong candidate for the Best Researcher Award.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Strong Publication Record in High-Impact Journals
    Dr. Zhou has consistently published in top-tier journals such as Nature Communications, Science Advances, Aging Cell, and Movement Disorders, reflecting the significance and innovation of her work. Many of these are Q1 journals with high impact factors.

  2. Focused Research on Neurodegeneration
    Her core focus on the molecular basis of Alzheimer’s and Parkinson’s disease, especially novel mechanisms like N-homocysteinylation, STAT1-PARP1, and microRNA signaling, demonstrates depth and relevance to global health priorities.

  3. Translational Impact
    Her research bridges basic science and clinical application, particularly through studies on neuroprotection, early disease biomarkers, and potential therapeutic targets.

  4. Early Career Excellence
    Despite being in the early stages of her career, Dr. Zhou has already authored or co-authored over 17 peer-reviewed publications, many as first or corresponding author, which is exceptional at this stage.

  5. Multidisciplinary Collaborations
    Dr. Zhou’s collaborations with experts across genetics, immunology, bioinformatics, and neurology highlight her integrative approach to complex diseases.

  6. International Visibility
    Multiple articles are indexed in PubMed, Crossref, and DOIs, showing her research has international academic presence and reach.

⚠️ Areas for Improvement:

  1. Greater International Exposure
    While her publication record is strong, further participation in international neuroscience conferences, workshops, or global consortia would enhance visibility and foster leadership roles.

  2. Grant Leadership and Independent Funding
    As she progresses, securing independent research funding and leading grant-funded projects will further demonstrate research independence and strengthen her candidacy for top-tier awards.

  3. Mentorship and Teaching Roles
    Involvement in structured mentorship or supervision of Ph.D./postdoctoral researchers could be better highlighted to show contributions to research training and capacity building.

  4. Innovation Translation Pathway
    Filing patents or initiating translational collaborations with biotech/pharma could underline the practical applicability of her findings.

🎓 Education:

Dr. Lingyan Zhou received her doctorate from Wuhan University, one of China’s leading research institutions, between September 2020 and June 2023. During her Ph.D. training, she developed expertise in molecular neuroscience and translational medicine, with a specific focus on the pathological mechanisms underlying Parkinson’s and Alzheimer’s diseases. Her research explored cellular stress pathways, protein misfolding, and epigenetic regulation in neurodegeneration, leading to multiple first-author publications in high-impact journals. Her academic background provided a solid foundation in experimental techniques such as immunohistochemistry, gene expression analysis, and in vivo disease modeling. The interdisciplinary approach at Wuhan University enriched her understanding of both clinical neurology and basic neuroscience. This rigorous academic training has equipped Dr. Zhou with the analytical and research skills necessary for advancing innovation in neurodegenerative disease treatment.

🧪 Experience:

Since July 2023, Dr. Lingyan Zhou has been serving in the Department of Neurology at Shandong Provincial Hospital affiliated with Shandong First Medical University, where she engages in both clinical practice and translational neuroscience research. Prior to that, she completed her doctoral studies at Wuhan University, where she developed a deep interest in the role of homocysteine metabolism and genetic regulation in Parkinson’s disease. Over her career, she has collaborated with multidisciplinary teams to investigate molecular and cellular mechanisms of neurodegeneration and published extensively in internationally recognized journals. Her current position allows her to continue high-impact research while mentoring junior colleagues and participating in multi-center studies. Her combined experience in basic research, clinical neurology, and academic collaboration has established her as a key contributor in the field of neurodegenerative diseases, positioning her well for leadership roles and research recognition such as the Best Researcher Award.

🧠 Research Focus:

Dr. Lingyan Zhou’s research is centered on understanding the molecular and cellular mechanisms that drive neurodegenerative diseases, with an emphasis on Alzheimer’s and Parkinson’s disease. Her work has shed light on pathological protein modifications, such as N-homocysteinylation of α-synuclein and DJ-1, which contribute to protein aggregation and neurotoxicity. Additionally, she investigates the neuroprotective roles of vitamins, retinoic acid, and microRNAs in slowing disease progression. Dr. Zhou is also exploring how infectious diseases like SARS-CoV-2 may trigger or exacerbate neurological disorders, expanding the understanding of systemic factors in brain health. Her studies leverage both in vitro and in vivo models to unravel pathways involving STAT1, PARP1, and Notch signaling. By identifying potential therapeutic targets and biomarkers, her research aims to guide the development of novel treatment strategies that could improve outcomes for patients suffering from movement disorders and cognitive decline.

📚 Publications Top Notes:

  1. 🧪 N-homocysteinylation of alpha-synuclein promotes its aggregation and neurotoxicity – Aging Cell (2022)

  2. 🧠 Association of vitamin B2 intake with cognitive performance in older adults: a cross-sectional study – J Transl Med (2023)

  3. 🧬 Homocysteine and Parkinson’s disease – CNS Neurosci Ther (2023)

  4. 🧴 Retinoic Acid Prevents alpha-Synuclein Preformed Fibrils-Induced Toxicity via Inhibiting STAT1-PARP1 Signaling – Mol Neurobiol (2023)

  5. 🧫 N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson’s disease – Aging Cell (2024)

  6. 🦠 SARS-CoV-2: Underestimated damage to nervous system – Travel Med Infect Dis (2020)

  7. 💊 Potential therapeutic drugs for ischemic stroke based on bioinformatics analysis – Int J Neurosci (2019)

  8. 🧬 PTPN22 Gene Polymorphisms and Stroke Susceptibility – Dis Markers (2019)

  9. 🧪 IL-18 Gene Polymorphisms and Risk of Ischemic Stroke: A Meta-analysis – Neuroreport (2019)

  10. 🚬 Aromatic hydrocarbon receptor links smoking and rheumatoid arthritis – Clin Exp Rheumatol (2020)

🧾 Conclusion:

Dr. Lingyan Zhou demonstrates an exceptional trajectory for a young neuroscience researcher. Her deep and original contributions to unraveling molecular mechanisms in neurodegeneration, particularly Parkinson’s and Alzheimer’s disease, make her highly deserving of recognition. The breadth and quality of her publication record—combined with her translational outlook—signal a rising star in neurodegenerative disease research.

Noura Hussein Abdel Hamid | Cell Structure Analysis | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Noura Hussein Abdel Hamid | Cell Structure Analysis | Best Researcher Award

Assist. Prof. Dr. Noura Hussein Abdel Hamid , Zagazig University , Egypt

Dr. Noura Hussein Abedel Hamid Mekawy is a dedicated Egyptian medical academic with extensive expertise in Histology and Cell Biology. Born on April 18, 1981, she graduated with an M.B.B.Ch. from Zagazig University in 2006, followed by a Master’s (2012) and an M.D. (2017) in Histology and Cell Biology from the same institution. Currently, she serves as a Lecturer at Zagazig University’s Faculty of Medicine. Her academic journey is complemented by her passion for medical education, microscopy, and molecular research. Dr. Mekawy has contributed to the field with multiple publications in reputable scientific journals, focusing on histopathological and immunohistochemical studies. She is a member of the Egyptian Society of Histology and Cytology and has completed professional training in self-evaluation and quality assurance in higher education. Her commitment to scientific advancement and education has established her as a respected figure in medical academia.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Extensive Research Background
    Dr. Mekawy has authored and co-authored 10 peer-reviewed publications, focusing on histopathology, immunohistochemistry, toxicology, and therapeutic interventions in experimental models.

  2. Specialization in a Vital Medical Field
    Her focus on Histology and Cell Biology is crucial for understanding disease mechanisms and developing new treatment strategies.

  3. Academic Progression & Teaching Role
    She has shown consistent career advancement from Demonstrator to Lecturer, demonstrating leadership and commitment in academia.

  4. Diverse Research Themes
    Her work explores the toxicological impacts of nanoparticles, pharmaceuticals, and environmental exposures, as well as the protective effects of antioxidants and stem cells—offering a well-rounded scientific profile.

  5. Professional Engagement
    Active member of Egyptian Society of Histology and Cytology and Medical Professions Syndicate, and involved in scientific conferences and training workshops.

  6. Methodological Strength
    Her skills in light/electron microscopy and immunohistochemical techniques indicate deep technical expertise.

⚙️ Areas for Improvement:

  1. Expand to International Collaborations
    Engaging in collaborative research with international institutions can increase visibility and impact.

  2. Publication in Higher Impact Journals
    While she has multiple publications, targeting high-impact Q1 journals can elevate the academic value of her research.

  3. Grant Funding & Project Leadership
    Applying for external research grants and leading funded projects would further enhance her research profile.

  4. Clinical Translation
    Bridging her findings from animal studies to clinical or translational research can broaden applicability.

🎓 Education:

Dr. Noura Mekawy earned her M.B.B.Ch. degree in Medicine and General Surgery from Zagazig University in October 2006, graduating with an excellent grade. Her strong academic foundation led her to pursue postgraduate studies in Histology and Cell Biology. In May 2012, she was awarded a Master’s degree with a thesis titled “The Effect of Maternal Exposure to Di (2-ethylhexyl) phthalate on The Lung of Albino Rat Offspring (Histological and Immunohistochemical Study).” She continued her academic progression by earning her M.D. in Basic Medical Sciences (Histology and Cell Biology) in January 2017. Throughout her studies, Dr. Mekawy demonstrated outstanding academic performance and developed a deep interest in cellular biology and histopathology. Her educational background reflects her commitment to advancing medical science through both practical research and academic instruction.

🧪 Experience:

Dr. Noura Mekawy began her academic career as a Demonstrator in the Histology and Cell Biology Department at Zagazig University in August 2008. She served in this role until May 2012, when she was promoted to Assistant Lecturer. In January 2017, following the completion of her M.D., she assumed the position of Lecturer in the same department. With over 15 years of experience in teaching and laboratory work, Dr. Mekawy has become proficient in histological techniques, immunohistochemistry, and electron microscopy. She is also skilled in data analysis using SPSS and Microsoft Office tools. Her responsibilities include teaching, supervising research projects, and contributing to curriculum development. Additionally, she has participated in educational quality assurance workshops and continues to mentor students and junior faculty members. Her teaching experience, combined with hands-on laboratory expertise, makes her a well-rounded educator and researcher.

🔬 Research Focus:

Dr. Mekawy’s research primarily focuses on histopathological and immunohistochemical changes in response to environmental, chemical, and pharmaceutical exposures in animal models. Her investigations are centered on understanding tissue damage and repair mechanisms in organs like the liver, lungs, testes, heart, submandibular glands, and the central nervous system. A consistent theme across her work is evaluating the protective or therapeutic roles of natural substances and pharmacological agents, including antioxidants like Vitamin E, Nigella sativa, and Zingerone, as well as advanced treatments such as salivary exosomes and stem cells. She integrates light microscopy, electron microscopy, and molecular biology techniques in her research. Dr. Mekawy is also engaged in evaluating the histological effects of nanoparticles and energy drinks on various tissues. Her contributions are valuable for toxicological assessment and potential therapeutic innovations, contributing to public health and medical safety.

📚 Publications Top Notes:

  1. 🧪 Effect of Silver Nanoparticles on Testes of Prepubertal Male Albino Rats and the Possible Protective Role of Vitamin E

  2. ⚠️ Hepatic Changes under the Effect of Red Bull Energy Drinks and its Withdrawal in Adult Male Albino Rats

  3. 💧 Therapeutic Role of Salivary Exosomes in Improving Histological and Biochemical Changes Induced by Duct Ligation in Submandibular Glands

  4. ❤️ The Possible Protective Effect of Zingiber Officinale on Cyclophosphamide-Induced Cardiotoxicity

  5. 👁️ Protective Effect of Chrysin on Corneal Structural Alterations Induced by Sofosbuvir

  6. 🧬 Nicorandil and Bone Marrow-Derived Mesenchymal Stem Cells in Ureteric Obstruction Recovery

  7. 🧠 Effect of Zinc Oxide Nanoparticles on Cerebellar Cortex of Adult Male Albino Rats

  8. 🥼 Protective Role of Ghrelin versus its Combination with Zingerone on Gastric Ischemic-Reperfusion

  9. 🔊 Effect of Low Frequency Noise on Heart and Lung & Role of Vitamin C

  10. 💪 Nandrolone Effect on Cardiac Muscle and Role of Nigella Sativa

🧾 Conclusion:

Dr. Noura Mekawy exhibits the hallmarks of a dedicated, capable, and innovative researcher in medical science. With over a decade of academic and research experience, she has made valuable contributions to experimental histology and cell biology. Her work is methodologically sound, thematically diverse, and medically relevant. The strength of her research, consistent publication record, and academic integrity make her a highly suitable candidate for the Best Researcher Award. Continued growth in publication quality, global collaboration, and translational research will further enhance her already impressive academic journey.

Yasmin M. Abd El-Aziz | Cell Structure Analysis | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Yasmin M. Abd El-Aziz | Cell Structure Analysis | Best Researcher Award

Assist. Prof. Dr. Yasmin M. Abd El-Aziz , Ministry of Higher Education, Port Said University, Port Said, Egypt., Egypt

Dr. Yasmin Mohamed Abd El-Aziz El-Sayed is a dedicated Egyptian researcher and academic specializing in Zoology, with deep expertise in cytology, histology, and genetics. Born on March 17, 1991, in Port Said, Egypt, she has built a robust scientific career rooted in excellence and innovation. Currently a faculty member at Port Said University, Dr. El-Sayed has contributed significantly to environmental toxicology, tissue pathology, and natural compound therapeutics. Her scholarly journey reflects a commitment to understanding biological systems and mitigating the impact of environmental pollutants on health. She has authored and co-authored numerous peer-reviewed publications, actively participated in educational platforms, and has held leadership roles in academic committees. Recognized by international and national journals, she exemplifies scientific rigor and a passion for education and research. Her work continues to impact both academic circles and public health strategies.

Publication Profile:

Google Scholar

✅ Strengths for the Award:

  1. Robust Publication Record 📚
    Dr. Yasmin has authored and co-authored over 20 peer-reviewed research papers across high-impact journals. Her research spans toxicology, histology, pharmacology, and aquaculture, with a strong presence in interdisciplinary studies.

  2. Innovative Research Focus 🔬
    She investigates the protective effects of natural compounds (e.g., curcumin, propolis, tamarind, pomegranate peel) on toxin-induced organ damage—critical for environmental health and therapeutic sciences.

  3. Contribution to Aquatic Health Science 🐟
    Her work on fish and shrimp nutrition, immunity, and resistance to pathogens significantly contributes to sustainable aquaculture, a pressing global need.

  4. Academic Leadership and Teaching 👩‍🏫
    With over a decade of university teaching experience and roles as a platform coordinator, trainer, and national committee member, she plays a pivotal role in shaping future scientists.

  5. Global Collaboration & Recognition 🌍
    She is associated with journals across the USA, India, and Egypt and actively collaborates internationally, as evidenced by co-authorships with global researchers.

⚙️ Areas for Improvement:

  1. More International Exposure
    While her publication record is commendable, more presentations at international conferences could increase her visibility and influence in global academic circles.

  2. Grant Acquisition and Independent Projects
    Securing research funding or leading international-funded projects would further demonstrate her capabilities as an independent principal investigator (PI).

  3. Translational Research and Patents
    Exploring patentable innovations or clinical applications of her findings (especially plant-based remedies) would enhance the real-world impact of her work.

🎓 Education:

Dr. Yasmin El-Sayed earned her B.Sc. in Biotechnology from the Faculty of Science at Port Said University in 2012, graduating first in her class with honors. Her undergraduate education was marked by extensive coursework in zoology, histology, genetics, microbiology, physiology, and toxicology. This strong foundation laid the groundwork for her future research in cellular biology and environmental toxicology. She further specialized in cytology, histology, and genetic engineering, with a keen interest in microtechnique, haematology, and advanced histological studies. Her academic training focused on both theoretical and practical aspects of tissue biology, pathology, and molecular genetics. These studies were pivotal in preparing her to conduct complex investigations into the effects of environmental toxins and therapeutic agents on animal models. With a strong grasp of molecular tools and histological techniques, Dr. El-Sayed continues to build on her academic expertise through cutting-edge research and academic collaborations.

🧑‍🏫 Experience:

Dr. Yasmin began her academic career as a Demonstrator in the Department of Zoology at Port Said University in 2012. Over the years, she progressed to the role of Assistant Lecturer in 2015, where she played a vital role in educating and mentoring undergraduate students. She has taught various courses including General Zoology, Histology and Histochemistry, Anatomy, and Microscopic Techniques. Her involvement extends beyond teaching, serving as a certified trainer for national initiatives like the Mawada Project and a coordinator for e-learning platforms such as Thinqi. She also plays a leading role in population development strategies at the faculty level. Her administrative and instructional contributions demonstrate her holistic approach to academic development. Dr. Yasmin combines research, teaching, and community service to foster a dynamic learning environment, enhancing both student experience and institutional growth.

🔬 Research Focus:

Dr. Yasmin El-Sayed’s research is primarily focused on toxicology, histopathology, cytogenetics, and therapeutic interventions using natural products. She investigates the biochemical and histological impacts of environmental toxins, including aluminum silicate, cadmium chloride, and iron oxide nanoparticles, on various organs in animal models. A significant component of her work involves evaluating the protective and antioxidant properties of natural extracts like propolis, pomegranate peel, Tegillarca granosa, and tamarind seeds. She is also engaged in aquatic animal health, exploring dietary interventions such as nano-curcumin, nano-selenium, and probiotics to improve the growth performance, immunity, and disease resistance in tilapia and shrimp. Her multi-disciplinary approach bridges molecular biology, histochemistry, and animal physiology, positioning her as a key contributor in both veterinary and biomedical research. Through her studies, she aims to develop natural, cost-effective treatments for toxin-induced damages, contributing to sustainable health and aquaculture solutions.

📚 Publications Top Notes:

  1. 🧠🧪 Protective effects of curcumin on cadmium chloride-induced bone/kidney toxicity in rats.

  2. 🧬🐀 Propolis protects against aluminum silicate toxicity in rats.

  3. 🧠🧬 Histopathological study: Egyptian propolis vs. aluminum silicate in rat cerebellum.

  4. 🧪📉 Prophylactic effect of propolis on multiple organs against aluminum silicate.

  5. 🧬🧫 Propolis defends liver from aluminum silicate: Biochemical and histological analysis.

  6. 🫁🛡 Propolis extract defends lung tissue against aluminum silicate: Antioxidant effects.

  7. 🐚🧬 Tegillarca granosa extract counters potassium bromide toxicity in rat liver and genes.

  8. 🧬🧫 Toxicity by sodium bicarbonate: Treatment using Cyperus esculentus tuber extract.

  9. 🤰🧬 Ehrlich carcinoma in pregnant mice: Tamarind extract shows protective effects.

  10. 🍎🧫 Pomegranate peel extract combats hepatotoxicity from iron oxide nanoparticles.

🧾 Conclusion:

Dr. Yasmin Mohamed Abd El-Aziz El-Sayed is highly suitable for the Best Researcher Award. Her diverse and impactful research, exceptional academic contributions, and dedication to scientific advancement make her a leading candidate. With continued growth in global engagement and translational outputs, she is poised to become an even more influential figure in the field of environmental toxicology and biomedical research.

Amira Ibrahim | Cell Differentiation Processes | Innovative Research Award

Published on by Cell Biologist

Dr. Amira Ibrahim | Cell Differentiation Processes | Innovative Research Award

Dr. Amira Ibrahim , Egyptian Atomic Energy Authority , Egypt

Dr. Amira Ibrahim Sayed is a dedicated academic and researcher, currently serving as a Lecturer at the National Center for Radiation Research and Technology, Atomic Energy Authority, Egypt. With a career grounded in oral medicine and radiology, Dr. Sayed demonstrates a multidisciplinary approach by integrating dental science with radiological and pharmaceutical research. She is known for her strong commitment to advancing healthcare through both education and scientific inquiry. Her diverse academic and professional background allows her to bridge the gap between clinical practice and biomedical research. Passionate about mentoring and teaching, she holds part-time academic roles at Misr University for Science and Technology. Dr. Sayed’s collaborative work in the synthesis of novel therapeutic agents highlights her innovative spirit and significant contributions to drug discovery, antiviral therapy, and radiation impact studies. Her impressive portfolio of peer-reviewed publications and participation in key academic courses make her a well-rounded candidate for the Research for Innovative Research Award.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Interdisciplinary Research Excellence
    Dr. Sayed merges expertise in oral medicine, radiology, and pharmaceutical chemistry—a rare and impactful blend. Her research spans both clinical and molecular levels, showing depth and versatility.

  2. Strong Publication Record
    With over 10 peer-reviewed publications in high-impact journals, her work is recognized across multiple fields including medicinal chemistry, antiviral therapy, and radiation sciences.

  3. Innovative Drug Discovery Focus
    Her work on the synthesis and molecular docking of pyrrolopyrimidine, benzimidazole, and thiouracil derivatives demonstrates cutting-edge innovation in developing novel therapeutic agents.

  4. Experience in Radiation Health Research
    Given her role at the National Center for Radiation Research & Technology, she actively contributes to important national research in radiation biology—an area of growing relevance.

  5. Academic and Educational Contributions
    As a lecturer at multiple institutions, she plays a vital role in knowledge transfer, student mentorship, and academic development.

  6. Multilingual Communication & Skills
    Her ability to communicate in Arabic, English, and basic German supports her involvement in international collaborations.

🛠 Areas for Improvement:

  1. Global Research Collaborations
    Greater participation in international collaborative projects, consortia, or funding initiatives would further elevate her impact and visibility.

  2. Patents and Practical Applications
    Filing for patents or translating her synthesized compounds into preclinical or clinical studies could reinforce the practical significance of her innovations.

  3. Increased Leadership Roles
    Engagement in leading research teams or coordinating large-scale projects could reflect greater influence within her scientific community.

🎓 Education:

Dr. Amira Ibrahim Sayed began her academic journey with a Bachelor’s degree in Dental Surgery (B.D.S) in 2005 from the Faculty of Oral and Dental Medicine, Cairo University. She further specialized in Oral Radiology, obtaining a Master of Science (M.Sc.) in 2014 from the same institution. Her academic curiosity and passion for interdisciplinary research led her to pursue a Ph.D. in Oral Medicine, Periodontology, Oral Diagnosis, and Radiology, which she completed in 2020 at Al-Azhar University. This diverse academic foundation has enabled her to explore the intersections of radiology, oral health, and medicinal chemistry. Dr. Sayed’s education reflects a strong emphasis on both clinical and scientific research skills, providing her with the expertise required to innovate in both diagnostic and therapeutic fields. Her comprehensive academic background makes her uniquely equipped to contribute to scientific research in radiation biology, oral diagnostics, and pharmaceutical innovation.

🧪 Experience:

Dr. Amira Ibrahim Sayed has amassed extensive academic and research experience, notably as a Lecturer at the National Center for Radiation Research & Technology, Atomic Energy Authority, since 2021. She started her professional journey there in 2015 as an Assistant Lecturer. Additionally, she contributes to higher education as a part-time Lecturer at Misr University for Science and Technology, where she also held an Assistant Lecturer role between 2015 and 2016. Her responsibilities include curriculum development, supervising student research, and lecturing in oral medicine and radiology. She has also actively participated in specialized training, such as the Ionizing Radiation Protection course, enhancing her qualifications in radiological safety. Her hands-on experience in both academic and applied research settings, combined with her interdisciplinary work in pharmacology and medical imaging, highlights her competence in navigating complex scientific challenges. Her professional trajectory is a testament to her adaptability, diligence, and commitment to innovation in health sciences.

🔬 Research Focus:

Dr. Amira Ibrahim Sayed’s research is centered around oral radiology, radiation protection, and the synthesis of novel pharmaceutical agents with therapeutic potential. Her interdisciplinary work bridges oral health sciences with medicinal chemistry, aiming to improve diagnostics and treatments in fields such as oncology, virology, and inflammation. She has explored the biological effects of magnetic resonance imaging and radiation on dental restorations and bone healing, highlighting her commitment to clinical relevance. Moreover, her innovative research on pyrrolopyrimidine and benzimidazole derivatives positions her at the forefront of drug discovery, particularly in antiviral, antifungal, and anti-inflammatory domains. Dr. Sayed utilizes molecular docking and simulation techniques to predict compound efficacy and mechanism of action. Her dedication to enhancing patient care through translational research, combined with a strong publication record in peer-reviewed journals, showcases her as a forward-thinking scientist making meaningful contributions to biomedical innovation.

📚 Publications Top Notes:

  1. 🧲 Effect of Magnetic Resonance Imaging on Microleakage of Amalgam Restoration

  2. 🦴 Radiographic and Histopathologic Evaluation of L-Carnitine and Vitamin E Efficacy on Irradiated Jaw Bones

  3. 🧪 Synthesis of Certain Pyrimidine Derivatives as Antimicrobial and Anti-inflammatory Agents

  4. 🧬 Design, Synthesis, and Molecular Docking of Pyrrolopyrimidine Derivatives as NS5B Polymerase Inhibitors

  5. 🦠 Novel Antiviral Compounds Against Gastroenteric Viral Infections

  6. 🧫 Synthesis of Novel Pyrroles and Fused Pyrroles as Antifungal and Antibacterial Agents

  7. 💊 Synthesis Strategies and Biological Value of Pyrrole and Pyrrolopyrimidine

  8. 🧯 Design and Evaluation of Pyrrolopyrimidine Derivatives as Antioxidant and Anti-inflammatory Agents

  9. 🦠 Evaluation of Pyrrolopyrimidine Derivatives as Antivirals Against Gastroenteric Viruses

📝 Conclusion:

Dr. Amira Ibrahim Sayed is a highly suitable candidate for the Research for Innovative Research Award. Her commitment to interdisciplinary innovation, particularly in radiation research and therapeutic compound development, aligns well with the award’s objective to honor groundbreaking scientific contributions. With a strong track record of impactful publications and academic leadership, she stands out as a researcher dedicated to improving health outcomes through science. Strengthening her global collaborations and translating research into applications will only further her potential for scientific excellence and recognition.